Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 31 | 2024 | 849 | 4.000 |
Why?
|
| Living Donors | 26 | 2024 | 339 | 2.850 |
Why?
|
| Kidney Failure, Chronic | 14 | 2020 | 509 | 2.340 |
Why?
|
| Tissue and Organ Procurement | 20 | 2024 | 311 | 1.960 |
Why?
|
| Transplant Recipients | 11 | 2021 | 122 | 1.490 |
Why?
|
| Registries | 21 | 2021 | 703 | 1.170 |
Why?
|
| Donor Selection | 11 | 2021 | 67 | 1.170 |
Why?
|
| Graft Survival | 14 | 2021 | 884 | 0.960 |
Why?
|
| Mobility Limitation | 1 | 2020 | 19 | 0.750 |
Why?
|
| Cognitive Dysfunction | 2 | 2019 | 132 | 0.740 |
Why?
|
| Graft Rejection | 4 | 2020 | 1065 | 0.740 |
Why?
|
| Vision Disorders | 1 | 2020 | 75 | 0.720 |
Why?
|
| Hearing Loss | 1 | 2020 | 56 | 0.720 |
Why?
|
| Disabled Persons | 1 | 2020 | 67 | 0.690 |
Why?
|
| Tissue Donors | 6 | 2019 | 463 | 0.690 |
Why?
|
| Tissue and Organ Harvesting | 7 | 2024 | 78 | 0.670 |
Why?
|
| Lens, Crystalline | 4 | 2013 | 69 | 0.600 |
Why?
|
| Nephrectomy | 7 | 2020 | 294 | 0.590 |
Why?
|
| Waiting Lists | 6 | 2021 | 175 | 0.570 |
Why?
|
| Regeneration | 3 | 2013 | 143 | 0.570 |
Why?
|
| Cognition | 3 | 2019 | 570 | 0.560 |
Why?
|
| Organ Transplantation | 4 | 2019 | 265 | 0.510 |
Why?
|
| Tretinoin | 2 | 2013 | 126 | 0.480 |
Why?
|
| United States | 23 | 2024 | 6674 | 0.480 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2013 | 79 | 0.470 |
Why?
|
| Frailty | 3 | 2019 | 58 | 0.460 |
Why?
|
| Community Health Workers | 3 | 2023 | 26 | 0.460 |
Why?
|
| Risk Factors | 15 | 2021 | 5417 | 0.440 |
Why?
|
| Adult | 29 | 2022 | 25648 | 0.400 |
Why?
|
| Mobile Applications | 2 | 2022 | 63 | 0.380 |
Why?
|
| Middle Aged | 27 | 2021 | 25028 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 623 | 0.370 |
Why?
|
| Prospective Studies | 9 | 2022 | 4213 | 0.370 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 827 | 0.340 |
Why?
|
| Humans | 51 | 2024 | 86645 | 0.340 |
Why?
|
| Cold Ischemia | 2 | 2019 | 17 | 0.340 |
Why?
|
| Health Plan Implementation | 2 | 2019 | 56 | 0.340 |
Why?
|
| HIV Infections | 3 | 2023 | 772 | 0.320 |
Why?
|
| Male | 29 | 2023 | 40967 | 0.310 |
Why?
|
| End Stage Liver Disease | 2 | 2018 | 61 | 0.310 |
Why?
|
| Prognosis | 9 | 2020 | 3680 | 0.300 |
Why?
|
| Social Media | 2 | 2019 | 79 | 0.300 |
Why?
|
| Female | 29 | 2023 | 44534 | 0.300 |
Why?
|
| Surgeons | 3 | 2019 | 238 | 0.280 |
Why?
|
| Follow-Up Studies | 11 | 2020 | 3640 | 0.280 |
Why?
|
| Signal Transduction | 2 | 2013 | 3241 | 0.280 |
Why?
|
| Survival Rate | 5 | 2020 | 1863 | 0.260 |
Why?
|
| Quality of Health Care | 2 | 2019 | 380 | 0.260 |
Why?
|
| Time Factors | 8 | 2020 | 5210 | 0.250 |
Why?
|
| Xenopus laevis | 3 | 2013 | 137 | 0.250 |
Why?
|
| Xenopus Proteins | 3 | 2013 | 34 | 0.250 |
Why?
|
| Motivational Interviewing | 2 | 2021 | 18 | 0.230 |
Why?
|
| Transplants | 2 | 2020 | 40 | 0.220 |
Why?
|
| Cell Phone | 1 | 2022 | 37 | 0.210 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1268 | 0.210 |
Why?
|
| Organ Preservation | 2 | 2019 | 83 | 0.210 |
Why?
|
| Delayed Graft Function | 2 | 2019 | 12 | 0.200 |
Why?
|
| Uganda | 4 | 2023 | 34 | 0.200 |
Why?
|
| Prevalence | 3 | 2021 | 1239 | 0.200 |
Why?
|
| Motivation | 2 | 2021 | 287 | 0.200 |
Why?
|
| Occupations | 1 | 2021 | 26 | 0.200 |
Why?
|
| Kidney | 6 | 2024 | 1241 | 0.190 |
Why?
|
| Life Style | 1 | 2022 | 189 | 0.190 |
Why?
|
| Alanine Transaminase | 1 | 2021 | 73 | 0.190 |
Why?
|
| Aspartate Aminotransferases | 1 | 2021 | 73 | 0.190 |
Why?
|
| Treatment Outcome | 8 | 2020 | 7993 | 0.190 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2020 | 23 | 0.190 |
Why?
|
| Postoperative Complications | 3 | 2020 | 2207 | 0.190 |
Why?
|
| Fathers | 1 | 2021 | 70 | 0.180 |
Why?
|
| Anxiety | 2 | 2021 | 287 | 0.180 |
Why?
|
| Transportation | 1 | 2019 | 18 | 0.180 |
Why?
|
| Medical Tourism | 1 | 2019 | 5 | 0.180 |
Why?
|
| Walking | 1 | 2020 | 87 | 0.180 |
Why?
|
| Aftercare | 1 | 2020 | 85 | 0.180 |
Why?
|
| Cysts | 1 | 2020 | 104 | 0.180 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 9 | 0.180 |
Why?
|
| Hepatitis C | 2 | 2018 | 208 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2020 | 227 | 0.170 |
Why?
|
| Health Promotion | 1 | 2021 | 160 | 0.170 |
Why?
|
| Preventive Health Services | 1 | 2019 | 37 | 0.170 |
Why?
|
| Dementia | 1 | 2021 | 187 | 0.170 |
Why?
|
| Cardiology | 1 | 2020 | 123 | 0.170 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1019 | 0.170 |
Why?
|
| Benchmarking | 1 | 2019 | 78 | 0.170 |
Why?
|
| Renal Dialysis | 2 | 2019 | 355 | 0.170 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 98 | 0.170 |
Why?
|
| Depression | 2 | 2021 | 473 | 0.160 |
Why?
|
| Transplantation | 1 | 2018 | 39 | 0.160 |
Why?
|
| Electronic Mail | 1 | 2018 | 14 | 0.160 |
Why?
|
| Health Education | 1 | 2018 | 101 | 0.160 |
Why?
|
| Epidemics | 1 | 2018 | 33 | 0.160 |
Why?
|
| Information Dissemination | 1 | 2018 | 103 | 0.160 |
Why?
|
| Motor Activity | 1 | 2020 | 327 | 0.160 |
Why?
|
| Communication | 2 | 2019 | 441 | 0.150 |
Why?
|
| Delirium | 1 | 2018 | 66 | 0.150 |
Why?
|
| Travel | 1 | 2017 | 68 | 0.150 |
Why?
|
| Risk Assessment | 6 | 2020 | 2262 | 0.150 |
Why?
|
| Drug Overdose | 1 | 2018 | 65 | 0.150 |
Why?
|
| Health Personnel | 1 | 2019 | 202 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 160 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 879 | 0.150 |
Why?
|
| Pica | 1 | 2016 | 14 | 0.140 |
Why?
|
| Self Care | 1 | 2018 | 164 | 0.140 |
Why?
|
| Telemedicine | 1 | 2019 | 169 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2020 | 376 | 0.140 |
Why?
|
| Incidence | 4 | 2021 | 1577 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2019 | 418 | 0.130 |
Why?
|
| Exercise | 1 | 2018 | 315 | 0.130 |
Why?
|
| Surveys and Questionnaires | 5 | 2022 | 2501 | 0.130 |
Why?
|
| Emotions | 1 | 2018 | 341 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 195 | 0.130 |
Why?
|
| Young Adult | 7 | 2019 | 5976 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1753 | 0.130 |
Why?
|
| Child Development | 1 | 2016 | 163 | 0.120 |
Why?
|
| Kidney Function Tests | 3 | 2020 | 123 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 426 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2018 | 510 | 0.120 |
Why?
|
| Aldehyde Oxidase | 1 | 2013 | 3 | 0.120 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2013 | 10 | 0.120 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 6 | 0.120 |
Why?
|
| Histocompatibility Testing | 3 | 2018 | 154 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 371 | 0.120 |
Why?
|
| Quality of Life | 2 | 2018 | 1585 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 3 | 2020 | 384 | 0.110 |
Why?
|
| Adolescent | 6 | 2024 | 8982 | 0.110 |
Why?
|
| Epithelium, Corneal | 1 | 2012 | 12 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 582 | 0.110 |
Why?
|
| Inflammation | 1 | 2018 | 920 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 31 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 273 | 0.110 |
Why?
|
| Cohort Studies | 4 | 2021 | 2767 | 0.110 |
Why?
|
| Aged | 8 | 2021 | 18415 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 806 | 0.100 |
Why?
|
| American Heart Association | 2 | 2022 | 92 | 0.100 |
Why?
|
| Hypertension | 1 | 2019 | 1141 | 0.090 |
Why?
|
| Blood Grouping and Crossmatching | 2 | 2021 | 14 | 0.090 |
Why?
|
| Eye | 1 | 2010 | 111 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 115 | 0.090 |
Why?
|
| Age Factors | 3 | 2019 | 1851 | 0.090 |
Why?
|
| Social Determinants of Health | 2 | 2021 | 78 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 159 | 0.090 |
Why?
|
| Counseling | 2 | 2023 | 145 | 0.090 |
Why?
|
| DNA, Cruciform | 1 | 2007 | 5 | 0.080 |
Why?
|
| Archaeal Proteins | 1 | 2007 | 18 | 0.080 |
Why?
|
| Archaea | 1 | 2007 | 18 | 0.080 |
Why?
|
| DNA, Single-Stranded | 1 | 2007 | 92 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2007 | 79 | 0.070 |
Why?
|
| Health Status | 2 | 2020 | 360 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1384 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 314 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2019 | 572 | 0.060 |
Why?
|
| Animals | 5 | 2020 | 26582 | 0.060 |
Why?
|
| Histocompatibility | 1 | 2024 | 71 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1673 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6509 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 1621 | 0.060 |
Why?
|
| Ecological Momentary Assessment | 1 | 2022 | 25 | 0.050 |
Why?
|
| Baltimore | 1 | 2020 | 36 | 0.050 |
Why?
|
| Intention to Treat Analysis | 1 | 2021 | 72 | 0.050 |
Why?
|
| Circumcision, Male | 1 | 2021 | 18 | 0.050 |
Why?
|
| Condoms | 1 | 2021 | 36 | 0.050 |
Why?
|
| Healthy Aging | 1 | 2020 | 8 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2022 | 751 | 0.050 |
Why?
|
| Longevity | 1 | 2020 | 51 | 0.050 |
Why?
|
| Standard of Care | 1 | 2020 | 79 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2022 | 839 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 115 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2019 | 51 | 0.040 |
Why?
|
| International Agencies | 1 | 2019 | 34 | 0.040 |
Why?
|
| Access to Information | 1 | 2019 | 27 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2019 | 50 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2019 | 53 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 43 | 0.040 |
Why?
|
| Independent Living | 1 | 2018 | 18 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 149 | 0.040 |
Why?
|
| Rehabilitation Centers | 1 | 2018 | 8 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 172 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2019 | 103 | 0.040 |
Why?
|
| Attitude | 1 | 2019 | 127 | 0.040 |
Why?
|
| Probability | 1 | 2019 | 355 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 319 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2022 | 8491 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2021 | 313 | 0.040 |
Why?
|
| Health Behavior | 1 | 2019 | 183 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2018 | 41 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 190 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 596 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2018 | 278 | 0.040 |
Why?
|
| Health Surveys | 1 | 2018 | 239 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 674 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2018 | 159 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2018 | 63 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2018 | 154 | 0.040 |
Why?
|
| Smartphone | 1 | 2017 | 36 | 0.040 |
Why?
|
| Cause of Death | 1 | 2018 | 277 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 567 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 865 | 0.040 |
Why?
|
| Anthropometry | 1 | 2016 | 74 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 257 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 83 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 351 | 0.030 |
Why?
|
| Rural Population | 1 | 2016 | 136 | 0.030 |
Why?
|
| Bangladesh | 1 | 2016 | 318 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1230 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 231 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2018 | 300 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1805 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 703 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 686 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2012 | 21 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1801 | 0.030 |
Why?
|
| Child | 1 | 2024 | 6928 | 0.030 |
Why?
|
| Larva | 1 | 2012 | 118 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 93 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 80 | 0.030 |
Why?
|
| Mitosis | 1 | 2012 | 153 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1718 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 91 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 268 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2705 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2012 | 254 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1036 | 0.020 |
Why?
|
| Physicians | 1 | 2018 | 673 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 301 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 121 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2012 | 429 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 3047 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 193 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 3613 | 0.020 |
Why?
|
| Retina | 1 | 2010 | 213 | 0.020 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2007 | 11 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 141 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 94 | 0.020 |
Why?
|
| DNA Replication | 1 | 2007 | 164 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 347 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 153 | 0.020 |
Why?
|
| Biological Transport | 1 | 2007 | 396 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 408 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1578 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2007 | 309 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 339 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 433 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 736 | 0.020 |
Why?
|
| Phylogeny | 1 | 2010 | 1137 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 1456 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 3968 | 0.010 |
Why?
|